Anti-Vascular Endothelial Growth Factor Treatment in Retinal Vein Occlusions

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|7|2|101-116

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.7, Iss.2, 2012-06, pp. : 101-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complications of Anti-Vascular Endothelial Growth Factor Drugs

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 131-137

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age- Related Macular Degeneration

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 90-95

Bentham Science Publishers

Access to resources Recommend Favorite

EDITORIAL [Hot Topic: Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Ophthalmic Conditions (Guest Editor: Michael W. Stewart)]

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 77-79

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) Biochemistry and Development of Inhibitory Drugs

By  

Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status of Vascular Endothelial Growth Factor Inhibition in Age-Related Macular Degeneration

By Mousa Shaker A.  

BioDrugs, Vol. 24, Iss. 3, 2010-06 ,pp. : 183-194

Adis International

Access to resources Recommend Favorite